Baran L, Siwanowicz J, Nowak G, Przegaliński E
Institute of Pharcacology, Polish Academy of Sciences, Kraków.
Pol J Pharmacol Pharm. 1991 Jul-Aug;43(4):265-70.
Captopril, an angiotensin converting enzyme inhibitor, was evaluated for a potential antidepressive activity in several animal models. The drug administered in doses of 3-30 mg/kg ip neither affected the reserpine- or apomorphine-induced hypothermia in mice nor reduced the immobility time in the forces swimming test in mice and rats. Moreover, captopril administered repeatedly (10 mg/kg ip, twice daily for 14 days) neither changed the density or affinity of cortical beta-adrenoceptors nor modified the nomifensine-induced locomotor hyperactivity in rats. These results suggest that captopril has no antidepressant-like activity in animal models.
卡托普利是一种血管紧张素转换酶抑制剂,已在多种动物模型中评估其潜在的抗抑郁活性。腹腔注射剂量为3 - 30 mg/kg的该药物,既不影响小鼠中利血平或阿扑吗啡诱导的体温过低,也不减少小鼠和大鼠强迫游泳试验中的不动时间。此外,反复给予卡托普利(腹腔注射10 mg/kg,每日两次,共14天)既不改变大鼠皮质β - 肾上腺素能受体的密度或亲和力,也不改变诺米芬辛诱导的大鼠运动性多动。这些结果表明,卡托普利在动物模型中没有抗抑郁样活性。